We are live on ! Find out more
OCUL icon

Ocular Therapeutix
OCUL

64 hedge funds and large institutions have $201M invested in Ocular Therapeutix in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

386% more call options, than puts

Call options by funds: $788K | Put options by funds: $162K

75% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 12

2% more capital invested

Capital invested by funds: $197M → $201M (+$3.54M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

10% less funds holding

Funds holding: 71 → 64 (-7)

44% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 16

Holders
64
Holders Change
-7
Holders Change %
-9.86%
% of All Funds
1.7%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
9
Increased
21
Reduced
12
Closed
16
Calls
$788K
Puts
$162K
Net Calls
+$626K
Net Calls Change
+$401K

Top Buyers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
+$4.91M
2
B
Bailard
California
+$1.66M
3
CI
Cowen Inc
New York
+$990K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$680K
5
CCI
Columbus Circle Investors
+$649K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.02M
2
Millennium Management
Millennium Management
New York
-$2.6M
3
O
OrbiMed
New York
-$1.45M
4
PCM
Portolan Capital Management
Massachusetts
-$1.42M
5
ARTA
A.R.T. Advisors
New York
-$898K
Name Holding Trade Value Shares
Change 		Change in
Stake
EDRS
26
Edmond de Rothschild (Suisse)
Switzerland
$435K – – –
Wells Fargo
27
Wells Fargo
California
$429K +$169K +22,360 +102%
RPAM
28
Rhenman & Partners Asset Management
Sweden
$386K +$303K +40,000 New
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$313K +$35K +4,625 +17%
PC
30
Polar Capital
United Kingdom
$290K -$37.9K -5,000 -14%
AA
31
ALPS Advisors
Colorado
$269K -$36.1K -4,767 -15%
Morgan Stanley
32
Morgan Stanley
New York
$220K +$126K +16,572 +265%
TA
33
Teachers Advisors
New York
$207K – – –
ProShare Advisors
34
ProShare Advisors
Maryland
$193K -$15.7K -2,069 -9%
V
35
Veritable
Delaware
$193K +$151K +20,000 New
Charles Schwab
36
Charles Schwab
California
$180K – – –
Swiss National Bank
37
Swiss National Bank
Switzerland
$156K +$28.8K +3,800 +29%
Canada Life
38
Canada Life
Manitoba, Canada
$155K – – –
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$144K – – –
BG
40
BlackRock Group
United Kingdom
$127K +$90.3K +11,926 +981%
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$124K – – –
AllianceBernstein
42
AllianceBernstein
Tennessee
$116K -$525K -69,260 -85%
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$105K +$6.92K +913 +9%
Citigroup
44
Citigroup
New York
$102K +$44.2K +5,833 +124%
DekaBank Deutsche Girozentrale
45
DekaBank Deutsche Girozentrale
Germany
$94K +$75.7K +10,000 New
NFA
46
Nationwide Fund Advisors
Ohio
$93K – – –
AIG
47
American International Group
New York
$74K – – –
PVI
48
Pura Vida Investments
New York
$58K +$45.4K +6,000 New
BA
49
BlackRock Advisors
Delaware
$49K +$9.48K +1,252 +32%
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
$48K +$32.3K +4,264 +579%
1
2
3 4

OCUL Hedge Fund Activity: Q1 2016 in Review

64 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Ocular Therapeutix (OCUL) for Q1 2016, worth a combined $201M — up 1.8% from $197M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of OCUL and 9 opened new positions — a net loss of 7 holders — while 12 trimmed existing stakes and 21 added.

The largest buyer was Jennison Associates, adding an estimated $4.91M. The largest seller was Fidelity Investments, cutting an estimated $4.02M.

  • 64 institutional investors held Ocular Therapeutix (OCUL) as of Q1 2016, down from 71 in Q4 2015.
  • Funds reported $201M of Ocular Therapeutix stock for Q1 2016, up 1.8% quarter-over-quarter.
  • 9 funds opened new Ocular Therapeutix positions in Q1 2016 and 16 closed out, a net change of -7 holders.
  • The largest Ocular Therapeutix buyer in Q1 2016 was Jennison Associates, an estimated $4.91M added.
  • The largest Ocular Therapeutix seller in Q1 2016 was Fidelity Investments, an estimated $4.02M sold.

Based on aggregated 13F filings for Q1 2016.